Literature DB >> 16530076

The management of superficial transitional cell carcinoma of the bladder.

Shomik Sengupta1, Michael L Blute.   

Abstract

Superficial transitional cell carcinomas (TCC) of the urinary bladder, defined as those that are restricted to the mucosa or the lamina propria, represent a common condition with a wide spectrum of biologic significance. High-grade superficial TCC, particularly in the presence of lamina propria invasion, has a significant risk of occult or subsequent progression to muscle-invasive or metastatic disease. Such high-risk lesions merit aggressive therapy with repeat resection followed by intravesical therapy, usually in the form of bacille Calmette-Guérin. Criteria for failure of intravesical therapy are not well defined, but persistent cytologic or cystoscopic abnormalities at 6 months are worrisome. Salvage intravesical therapy may sometimes be successful, but early cystectomy should be strongly considered, especially in younger patients. Close surveillance of patients with high-risk superficial TCC is essential.

Entities:  

Mesh:

Year:  2006        PMID: 16530076     DOI: 10.1016/j.urology.2006.01.041

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  12 in total

Review 1.  Contemporary management of low-risk bladder cancer.

Authors:  Johannes Falke; J Alfred Witjes
Journal:  Nat Rev Urol       Date:  2011-01       Impact factor: 14.432

Review 2.  Use of nomograms as predictive tools in bladder cancer.

Authors:  Ahmad Shabsigh; Bernard H Bochner
Journal:  World J Urol       Date:  2006-11       Impact factor: 4.226

3.  Clinical significance of urine heparanase in bladder cancer progression.

Authors:  Itay Shafat; Dov Pode; Tamar Peretz; Neta Ilan; Israel Vlodavsky; Benjamin Nisman
Journal:  Neoplasia       Date:  2008-02       Impact factor: 5.715

Review 4.  Biological/pathological functions of the CXCL12/CXCR4/CXCR7 axes in the pathogenesis of bladder cancer.

Authors:  Alireza Nazari; Hossein Khorramdelazad; Gholamhossein Hassanshahi
Journal:  Int J Clin Oncol       Date:  2017-10-11       Impact factor: 3.402

5.  Survival after primary and deferred cystectomy for stage T1 transitional cell carcinoma of the bladder.

Authors:  Bedeir Ali-El-Dein; Mohammed S Al-Marhoon; Mohamed Abdel-Latif; Ahmed Mesbah; Atallah A Shaaban; Adel Nabeeh; El-Housseiny I Ibrahiem
Journal:  Urol Ann       Date:  2011-09

6.  Bladder cancer biomarker discovery using global metabolomic profiling of urine.

Authors:  Bryan M Wittmann; Steven M Stirdivant; Matthew W Mitchell; Jacob E Wulff; Jonathan E McDunn; Zhen Li; Aphrihl Dennis-Barrie; Bruce P Neri; Michael V Milburn; Yair Lotan; Robert L Wolfert
Journal:  PLoS One       Date:  2014-12-26       Impact factor: 3.240

Review 7.  Urinary tract cancers: An overview for general practice.

Authors:  Julian P Yaxley
Journal:  J Family Med Prim Care       Date:  2016 Jul-Sep

8.  Prospective evaluation of the efficacy of antibiotic prophylaxis before cystoscopy.

Authors:  Kamil Cam; Ali Kayikci; Ali Erol
Journal:  Indian J Urol       Date:  2009-04

9.  Noninvasive multianalyte diagnostic assay for monitoring bladder cancer recurrence.

Authors:  Neal D Shore; Cecilia A Fernandez; Anthony P Shuber
Journal:  Res Rep Urol       Date:  2012-10-18

10.  Urotensin II receptor determines prognosis of bladder cancer regulating cell motility/invasion.

Authors:  Renato Franco; Silvia Zappavigna; Vincenzo Gigantino; Amalia Luce; Monica Cantile; Margherita Cerrone; Gaetano Facchini; Sisto Perdonà; Sandro Pignata; Giuseppe Di Lorenzo; Sergio Chieffi; Giovanni Vitale; Marco De Sio; Alessandro Sgambato; Gerardo Botti; Ali Munaim Yousif; Ettore Novellino; Paolo Grieco; Michele Caraglia
Journal:  J Exp Clin Cancer Res       Date:  2014-06-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.